Tag: Stem Cells
Leukemia Stem Cell-Based Method Aids Relapse Prediction in Acute Myeloid Leukemia
Findings seen compared with traditional multiparameter flow cytometry assay in patients undergoing allografts
Age, Disease Duration Are Predictors of CKD After Stem Cell Transplant
Age and hematologic disease length are positive predictors for CKD; acute lymphoblastic leukemia is a negative predictive factor
Allogeneic HCT Feasible in Older Patients With Myelodysplastic Syndrome
After propensity score matching, overall survival, PFS, nonrelapse mortality did not significantly differ for those 65 years and older versus younger than 65 years
AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT
Machine learning model outperformed all comparators and achieved better concordance indices across myelofibrosis subgroups
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
Ryoncil is first FDA-approved mesenchymal stromal cell therapy for pediatric patients aged 2 months or older
Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant Recipients
Itacitinib results in low cytokine release syndrome grades, low incidence of acute, chronic graft versus host disease
ASH: Auto-HCT Not Beneficial for Mantle Cell Lymphoma With Undetectable Residual Disease
Overall survival no better for those receiving autologous HCT plus maintenance rituximab versus rituximab alone
Overall Survival Improving for Umbilical Cord Blood Transplant
Inferior overall survival seen in Latine adults compared with Black patients in a multivariable analysis
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups
Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell
Improvement seen in diffusing capacity of the lungs for carbon monoxide and in the six-minute walk test
